Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study

There are no reports regarding the efficacy of sodium-glucose cotransporter 2 inhibitor (SGLT2i) and dipeptidyl peptidase 4 inhibitor (DPP4i) administrations in nonalcoholic fatty liver disease (NAFLD) patients without type 2 diabetes mellitus. The purpose of this study was to evaluate the efficacy...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Biochem Nutr
Glavni autori: Tobita, Hiroshi, Yazaki, Tomotaka, Kataoka, Masatoshi, Kotani, Satoshi, Oka, Akihiko, Mishiro, Tsuyoshi, Oshima, Naoki, Kawashima, Kousaku, Ishimura, Norihisa, Naora, Kohji, Sato, Shuichi, Ishihara, Shunji
Format: Artigo
Jezik:Inglês
Izdano: the Society for Free Radical Research Japan 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046003/
https://ncbi.nlm.nih.gov/pubmed/33879970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.20-129
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items